Rexford Capital’s AstraZeneca AZN Stock Holding History

Rexford Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.28M	Buy	6,735 +7	+0.1%	+$1.32K	0.78%	30
2026 Q1	$1.33M	Buy	6,728 +2	+0%	+$386	0.95%	25
2025 Q4	$1.24M	Sell	6,726 -111	-2%	-$19.5K	0.94%	23
2025 Q3	$1.05M	Buy	6,837 +54	+0.8%	+$8.17K	0.81%	31
2025 Q2	$948K	Buy	+6,783	New	+$951K	0.79%	37

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Rexford Capital's AZN Position: Q2 2026 in Review

Rexford Capital increased its AstraZeneca (AZN) stake by 0.1% in Q2 2026, buying an estimated $1.32K and bringing the position to 6,735 shares worth $1.28M. The position accounts for 0.78% of the portfolio, ranked #30.

Rexford Capital first reported a position in AZN in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.33M in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Rexford Capital held 6,735 shares of AstraZeneca worth $1.28M as of Q2 2026.
Rexford Capital bought 7 AstraZeneca shares in Q2 2026, an estimated $1.32K.
AstraZeneca made up 0.78% of Rexford Capital's portfolio in Q2 2026, its #30 holding.
Rexford Capital first reported a position in AstraZeneca in Q2 2025 and has held it in 5 quarters since.
Rexford Capital's AstraZeneca position peaked at $1.33M in Q1 2026.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Rexford Capital's 13F filing for Q2 2026, filed 29 Jul 2026.